Reducose is proven by science
How it works
The active compounds in Reducose are sugar mimetics called iminosugars. These compounds ‘look’ like glucose and are able to inhibit the enzymes that break carbohydrates into glucose molecules for absorption into the body. As the carbohydrates aren’t digested, the glucose in foods and drinks never enters the body.
Over a series of clinical studies, Reducose has been proven to lower the glycaemic index of common carbohydrates, to lower blood glucose spikes and total blood glucose after eating foods and drinks containing sugar and/or carbohydrates, and to lower blood insulin levels.
Insulin resistance is the name given when cells don’t respond properly to insulin and is one of the key drivers behind prediabetes and type-2 diabetes. Reducose has been shown to prevent the development of insulin resistance and helps maintain proper functioning of the insulin receptors.
Reducose can be used in a wide range of foods products. Adding Reducose lowers the glycaemic index of the food and the subsequent glycaemic response
Reducose can be added to drinks containing sugar to lower the impact of sugar in drink on the body, whilst retaining the gold-standard sugar taste
Reducose can be added to foods and drinks designed to meet the specific dietary requirements of diabetic patients. Reducose lowers blood glucose spikes and long-term use may improve insulin sensitivity
Reducose can be used on its own or in combination with other ingredients in dietary supplements to help people maintain healthy blood glucose levels
Reducose has been recognised in various international and national awards for its innovative approach to making foods healthier. Read more about these awards, peer-reviewed scientific studies, and national regulatory approvals.
Reducose® awarded the New Power China “Functional Ingredient Innovation Award” at the China Natural Health Industry Conference in Shanghai, 25 October 2018November 16, 2018
UK government identifies Reducose as a novel ingredient that could help prevent diabetesFebruary 24, 2017
PLOS One publishes clinical proof of efficacy of ReducoseFebruary 23, 2017
16 Blenheim Office Park, Long Hanborough, OX29 8LN, UK
+44 1993 880 700